Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Deferred Taxes (2016 - 2025)

Utah Medical Products (UTMD) has 15 years of Deferred Taxes data on record, last reported at -$281000.0 in Q3 2025.

  • For Q3 2025, Deferred Taxes fell 430.19% year-over-year to -$281000.0; the TTM value through Sep 2025 reached -$583000.0, up 29.42%, while the annual FY2024 figure was -$359000.0, 48.2% up from the prior year.
  • Deferred Taxes reached -$281000.0 in Q3 2025 per UTMD's latest filing, down from -$151000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $230000.0 in Q2 2021 and bottomed at -$409000.0 in Q4 2023.
  • Average Deferred Taxes over 5 years is -$115052.6, with a median of -$144000.0 recorded in 2022.
  • Peak YoY movement for Deferred Taxes: soared 1233.33% in 2021, then tumbled 6300.0% in 2024.
  • A 5-year view of Deferred Taxes shows it stood at $68000.0 in 2021, then crashed by 88.24% to $8000.0 in 2022, then plummeted by 5212.5% to -$409000.0 in 2023, then skyrocketed by 114.18% to $58000.0 in 2024, then plummeted by 584.48% to -$281000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Deferred Taxes were -$281000.0 in Q3 2025, -$151000.0 in Q2 2025, and -$209000.0 in Q1 2025.